研究生: |
蔡仲昕 Chung-Hsin Tsai |
---|---|
論文名稱: |
探利用大白鼠模式探討新生期投予 Dexamethasone 對杏仁核中麩胺酸突觸傳遞的影響 The Effects of Neonatal Dexamethasone Treatment on Amygdaloid Glutamatergic Synaptic Transmission in Juvenile Rats |
指導教授: |
呂國棟
Lu, Kwok-Tung |
學位類別: |
碩士 Master |
系所名稱: |
生命科學系 Department of Life Science |
論文出版年: | 2014 |
畢業學年度: | 102 |
語文別: | 中文 |
論文頁數: | 66 |
中文關鍵詞: | Dexamethasone(DEX) 、杏仁核 、長效增益 |
英文關鍵詞: | Dexamethasone, Amygdale, Long-term potentiation |
論文種類: | 學術論文 |
相關次數: | 點閱:149 下載:5 |
分享至: |
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報 |
Dexamethasone(DEX)是一種人工合成的糖皮質激素,目前廣泛的作為消炎藥劑,及用於治療早產兒的呼吸窘迫症。前人的研究結果顯示,新生時期DEX的投藥,會影響海馬迴的功能,導致青少年期的記憶障礙。但是否會對杏仁核之功能造成影響?及其詳細機制,則仍有待進一步探討。因此,本研究將探討新生時期的DEX投藥,對青春期大鼠杏仁核功能的可能影響。對出生後第一至三天的Wistar大鼠以皮下注射方式,投予遞減劑量之DEX (0.5 mg/kg, 0.3 mg/kg和0.1mg/kg)。於6週齡時,以電生理紀錄來評估杏仁核的功能。結果顯示,DEX處理過的大鼠於出生第三天至六週齡時的體重有顯著降低。新生期經DEX處理的大鼠,不僅損害杏仁核處之長效增益(LTP)的反應,也增強了在急性壓力曝露後的類憂鬱行為。而給予NMDA受體促進劑D-cycloserine後的這些初步結果顯示,新生時期的DEX投藥,會對大鼠的杏仁核功能產生長期的影響,其機轉可能與影響杏仁核中麩胺酸的傳遞有關。本研究想闡明對新生時期給予DEX,對大鼠青春期杏仁核中麩胺酸神經傳遞影響的機制。為了證實這一目標,以DCS進行實驗發現可以改善新生期投予DEX的大鼠LTP誘發障礙的現象。此外,使用西方墨漬法,發現杏仁核細胞中麩胺酸NMDA受體的表現量並無顯著差異,但是新生期投予DEX的大鼠杏仁核細胞中NKCC1受體的表現量顯著低於 saline組。
Dexamethasone (DEX) is a synthetic glucocorticoid and has been widely used as an anti-inflammatory agent and also used to treat respiratory distress syndrome in preterm infants. Although numerous reports indicated that neonatal DEX exposure may altered neural plasticity in hippocampus leading to memory impairment, the possible long-term adverse effect of neonatal DEX treatment on amygdale have not yet been examine properly. Therefore, we completed a series of pilot experiments to investigate the possible effect of neonatal DEX treatment on amygdale function in adult rats. In brief, Wistar rats were subjected for subcutaneous injection with tapering dose of DEX (0.5 mg/kg, 0.3 mg/kg and 0.1mg/kg) from postnatal day 1 to 3, PN1~PN3. Electrophysiological recording and forced swimming test were employed to evaluate the amygdale function at the age of 6 weeks. Results showed that DEX-treated rats exhibited a significant reduction in somatic weights during adolescence, but did not affect in adult stage. Neonatal DEX treatment not only impaired long-term potentiation (LTP) response in amygdale but also enhance the depression-like behavior after acute stress exposure. Our results also found that superfusion partially with either NMDA agonist D-cycloserine could restore the formation of LTP in amygdala. These results suggested that neonatal DEX treatment has long-term adverse effect on amygdale function and probably via receptor level mechanism especially a glutamatergic transmission might be involved. The present study is aimed to elucidate the detail mechanism of neonatal DEX treatment effects on the amygdaloid glutamatergic neurotransmission. To achieve this goal, an antagonistic design will be proceed to verify our preliminary results. In addition, western blotting was applied to evaluate the expression level and cellular distribution of glutamate NMDA receptor within amygdale after neonatal DEX treatment. No significant difference on the expression of amygdaloid NMDA receptors among groups had been found.
Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt D (1998) The MAPK cascade is required for mammalian associative learning. Nature Neuroscience 1: 602–609.
Bifulco A, Brown GW, Adler Z (1991) Early sexual abuse and clinical depression in adult life. The British Journal Psychiatry 159:115-122.
Blaesse P, Airaksinen MS, Rivera C, Kaila K (2009) Cation-chloride cotransporters and neuronal function. Neuron 61: 820–838.
Bliss TV, Gardner AR (1973) Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. Journal of Physiology 232:357-374.
Borsini, Franco, Giovanna V, and Alberto M (1986) Does the behavioral “despair” test measure “despair”? Physiology and Behavior 38: 385-386.
Busse S, Breder J, Dinkel K, Reymann KG, Schröder UH (2005) Inhibitors of cation-chloride-cotransporters affect hypoxic/ hypoglycemic injury in hippocampal slices. Brain Research 1046:116–121.
Butler TR, Ariwodola OJ, Weiner JL (2013) The impact of social isolation on HPA axis function, anxiety-like behaviors, and ethanol drinking. Frontiers in Integrative Neuroscience 7:102. doi: 10.3389/fnint.2013.00102.
Campeau S, Davis M (1995) Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. The Journal of Neuroscience 15:2301-2311.
Caspi A, Reichenberg A, Weiser M, Rabinowitz J, Kaplan Z, Knobler H, Davidson-Sagi N, Davidson M (2003) Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode. Schizophrenia Research 65:87-94
Castellucci VF, Frost WN, Goelet P, Montarolo PG, Schacher S, Morgan JA, Blumenfeld H, Kandel ER (1986) Cell and molecular analysis of long-term sensitization in Aplysia. Journal of Physiology 81:349-357.
Charles R. Neal Jr, Gabrielle W, Mohamed K, and Delia M. Va´zquez (2004) Effect of neonatal dexamethasone exposure on growth and neurological development in the adult rat. American Journal Physiology Regulator Integrative and Comparative Physiology 287: R375–R385.
Chen HJ, Rojas-Soto M, Oguni A, Kennedy MB (1998) A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20:895–904
Chen MH, Lin JH, Lin CH (2012) Identification for the Specific Depression-like Behavior of 60-Minute Maternal Deprivation Rats in Early Life. Life Science Journal 9:548
Chetkovich DM, Gray R, Jonhston D, Sweatt JD (1991) N-methyl-D-aspartate receptor activation increases cAMP levels and voltage-gated Ca2+ channel activity in area CA1 of hippocampus. Proceedings of the National Academy of Sciences 88:6467–6471
Chiswick M (1995) Antenatal TRH. Lancet 345:872-873.
Claessens SEF, Daskalakis NP, Oitzl MS, de Kloet ER (2012) Early handling modulates outcome of neonatal dexamethasone
exposure. Hormones and Behavior 62:433–441.
Crowley P (2006) Prophylactic corticosteroids for preterm birth. The Cochrane Library.
Dallman MF, Akana SF, Jacobson L, Levin N, Cascio CS, Shinsako J (1987) Characterization of corticosterone feedback regulation of ACTH secretion. Annals of the New York Academy Sciences 512:402-414.
Denys D, de Geus F (2005) Predictors of pharmacotherapy response in anxiety disorders. Current Psychiatry Reports 7: 252–257.
de Vries WB, van den Borne P, Goldschmeding R, de Weger RA, Bal MP, van Bel F, van Oosterhout MF (2010) Neonatal dexamethasone treatment in the rat leads to kidney damage in adulthood. Pediatric Research 67.1:72-76.
Dobbing J (1981) The later development of the brain and its vulnerability. Journal of Inherited Metabolic Disease 5:88-88.
Dzhala VI, Kuchibhotla KV, Glykys JC, Kahle KT, Swiercz WB, Feng G, Kuner T, Augustine GJ, Bacskai BJ, Staley KJ (2010) Progressive NKCC1-dependent neuronal chloride accumulation during neonatal seizures. The Journal of Neuroscience 30:11745-11761.
Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ (2005) NKCC1 transporter facilitates seizures in the developing brain. Nature Medicine 11:1205–1213.
Fanselow MS, LeDoux JE (1999) Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron 23:229-32.
Fendt M (2001) Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing. The Journal of Neuroscience 21:4111-4115.
Fiumelli H, Woodin MA (2007) Role of activity-dependent regulation of neuronal chloride homeostasis in development. Current Opinion in Neurobiology 17:81-86.
Fuchs E, Czeh B, Kole MH, Michaelis T, Lucassen PJ (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. European Neuropsychopharmacology 14:S481-490.
Gewirtz J C, Davis M (1997) Second-order fear conditioning prevented by blocking NMDA receptors in amygdala. Nature 388:471-474.
Grewal SS, York RD, Stork PJ (1998) Extracellular-signal-regulated kinase signalling in neurons. Current Opinion in Neurobiology 9:544-553
Haglund MM, Hochman DW (2005) Furosemide and mannitol suppression of epileptic activity in the human brain. Journal of Neurophysiology 94:907-918.
Hannaert P, Alvarez-Guerra M, Pirot D, Nazaret C, Garay RP (2002) Rat NKCC2/NKCC1 cotransporter selectivity for loop diuretic drugs. Naunyn-Schmiedeberg's Archives of Pharmacology 365:193-199.
Hirschfeld RMA (2003) Long-term side effects of SSRIs: sexual dysfunction and weight gain. Journal of Clinical Psychiatry 64:20-24.
Hochman DW, Schwartzkroin PA (2000) Chloride-cotransport blockade desynchronizes neuronal discharge in the ‘‘epileptic’’ hippocampal slice. Journal of Neurophysiology 83: 406-417.
Imanaka A, Morinobu S, Toki S, Yamawaki S (2006) Importance of early environment in the development of post-traumatic stress disorder-like behaviors. Behavioral Brain Research 173:129-137.
Impey S, Obrietan K, Storm DR (1999) Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23:11-14.
Isenring P, Forbush B (2001) Ion transport and ligand binding by the Na-K-Cl cotransporter, structure function studies. Comparative Biochemistry and Physiology Part A 130:487-497.
Jumper SA (1995) A meta-analysis of the relationship of child sexual abuse to adult psychological adjustment. Child Abuse and Neglect 19(6):715-28
Kahle KT, Staley KJ (2008) The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures. Journal of Neurosurgery 25:E22.
Kendler KS, Davis CG, Kessler RC (1997) The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. The British Journal of Psychiatry 170:541–548.
Kendler KS, Gardner CO (2010) Dependent stressful life events and prior depressive episodes in the prediction of major depression: the problem of causal inference in psychiatric epidemiology. Archives of General Psychiatry 67:1120–1127.
Kilb W, Sinning A, Luhmann HJ (2007) Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse. Neuropharmacology 53:524-33.
Kim JH, Lee SJ, Rim HD, Kim HW, Bae GY, Chang SM.(2008) The Relationship between Alexithymia and General Symptoms of Patients with Depressive Disorders. Journal of Korea Neuropsychiatric Association 5(3):179-85
Kim JJ, DeCola JP, Landeria-Fernandez J, Fanselow MS (1991) N-methyl-D- aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behavioral Neuroscience 105:126-133.
Kitamura A, Ishibashi H, Watanabe M, Takatsuru Y, Brodwick M, Nabekura J (2008) Kitamura A, Ishibashi H, Watanabe M, Takatsuru Y, Brodwick M, Nabekura J. Neuroscience Research 62(4):270-7
Korte SM, Boer SF, Kloet ER, Bohus B (1995) Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology 20:385-394.
Krystal D, Sutherland J, Hochman DW (2012) Loop diuretics have anxiolytic effects in rat models of conditioned anxiety PLoS One 7(4):e35417
LeDoux JE, Cicchetti P, Xagoraris A, Romanski LM (1990) The lateral amygdaloid nucleus: sensory interface of the amygdala in fear conditioning. The Journal of Neuroscience 10:1062-1069.
Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, Chien LY, Sale J (2000) Variations in practice and outcomes in the Canadian NICU network: 1996-1997. Pediatrics 106:1070-1079.
Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK (2001) Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Lin HJ, Huang CC, Hsu KS (2006) Effects of neonatal dexamethasone treatment on hippocampal synaptic function. Annals of Neurology 59:939-951.
Lin CH, Yeh SH, Lu HY, Gean PW (2003) The similarities and diversities of signal pathways leading to consolidation of conditioning and consolidation of extinction of fear memory. The Journal of Neuroscience 23:8310-8317
Lin HJ, Huang CC, Hsu KS (2006) Effects of neonatal dexamethasone treatment on hippocampal synaptic function. Annals of Neurology 59:939-951.
Lopez-Samblas AM, Adams JA, Goldberg RN, Modi MW (1997) The pharmacokinetics of bumetanide in the newborn infant. Biology of the Neonate 72:265-72.
Lu KT, Wu CY, Cheng NC, Wo YYP, Yang JT, Yen HH, Yang YL (2006) Inhibition of the Na+-K+-2Cl−-cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage. European Journal of Pharmacology 548:99-105.
Lu KT, Cheng NC, Wu CY, Yang YL (2008) NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf/MEK/MAPK cascade. Critical Care Medicine 36:917-922.
Lu KT, Walker DL, Davis M (2001) Mitogen-activated protein kinase cascade in the basolateral nucleus of amygdala is involved in extinction of fear-potentiated startle. The Journal of Neuroscience 21(16):RC162.
McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, DeChant HK, Ryden J, Derogatis LR, Bass EB (1997) Clinical characteristics of women with a history of childhood abuse: unhealed wounds. The Journal of the American Medical Association 277:1362-1368.
Maren S (1999) Neurotoxic basolateral amygdala lesion impair learning and memory but not the performance of conditional fear in rats. The Journal of Neuroscience 19:8696-8703.
Maren S, Aharonow G, Fanselow (1996) Retrograde abolition of conditioned fear after excitotoxic lesions in the basolateral amygdala of rats: absence of a temporal gradient. Behavioral Neuroscience 110:718-726.
Miserendino MJD, Sananes CB, Melia KR, Davis M (1990) Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature 345:716-718.
Molanr BE, Buka SL, Kessler RC (2001) Child sexual abuse and subsequent psychopathology: results from the National Comorbidity Survey. American Public Health Association 91(5):753-60.
Mount DB, Delpire E, Gamba G, Hall AE, Poch E, Hoover RS, Hebert SC (1998) The electroneutral cation-chloride cotransporters. The Journal of Experimental Biology 201:2091-2102.
Nagano M, Liu M, Inagaki H, Kawad T, Suzuki H (2012) Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone. Neuropharmacology 63:292-300
Nagano M, Ozawa H, Suzuki H (2008) Prenatal dexamethasone exposure affects anxiety-like behaviour and neuroendocrine systems in an age-dependent manner. Neuroscience Research 60:364-371.
Nair,A, Bonneau RH (2006) Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. Journal of Neuroimmunology 171:72–85.
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13-25.
O'Donnell ME, Train L, Lam TI, Liu XB, Anderson SE (2004) Bumetanide inhibition of the blood brain barrier Na–K–Cl cotransporter reduces edema formation in the rat middle cerebral artery occlusion model of stroke. Journal of Cerebral Blood Flow & Metabolism 24:1046–1056.
Paolucci EO, Genuis ML, Violato C (2001) A meta-analysis of the published research on the effects of child sexual abuse. The Journal of Psychology 135(1):17-36
Pariante CM (2003). Depression, Stress and the Adrenal axis. Journal of Neuroendocrinology 15: 811–812.
Payne JA, Forbush B (1995) Molecular characterization of the epithelial Na-K-Cl cotransporter isoforms. Current Opinion in Cell Biology 7:493-503.
Quirarte GL, Roozendaal B, McGaugh JL (1997) Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proceedings of the National Academy Science 94:14048-14053.
Ravindran LN, Stein MB (2010) The pharmacologic treatment of anxiety disorders: a review of progress. Journal of Clinical Psychiatry 71:839–854.
Renoir T, Hasebe K, Gray L (2013) Mind and body: how the health of the body impacts on neuropsychiatry. Frontiers in Pharmacology 4:158
Roozendaal B (2002) Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiology of Learning and Memory 78:578-595.
Schwartzkroin PA, Baraban SC, Hochman DW (1998) Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Research 32:275–285.
Sivakumaran S, Mohajerani MH, Cherubini E (2009) At immature mossy-fiber-CA3 synapses, correlated presynaptic and postsynaptic activity persistently enhances GABA release and network excitability via BDNF and cAMP-dependent PKA. The Journal of Neuroscience 29(8):2637-47
Smith SL, Kirchhoff KT, Chan GM, Squire SJ (1994) Patterns of postnatal weight changes in infants with very low and extremely low birth weights. Heart Lung 23:439-445.
Somm E, Vauthay DM, Gue´rardel A, Toulotte A, Cettour-Rose P, et al. (2012) Early metabolic defects in dexamethasone-exposed and undernourished intrauterine growth restricted rats. PLoS ONE 7(11): e50131.
Su G, Kintner DB, Flagella M, Shull GE, Sun D (2002a) Astrocytes from Na+-K+-Cl- cotransporter-null mice exhibit absence of swelling and decrease in EAA release. American Journal of Physiology 282:C1147–C1160.
Su G, Kintner DB, Sun D (2002b) Contribution of Na+-K+-Cl- cotransporter to high-[K+]o induced swelling and EAA release in astrocytes. American Journal of Physiology 282:C1136–C1146.
Sullivan JE, Witte MK, Yamashita TS, Myers CM, Blumer JL (1996) Dose-ranging evaluation of bumetanide pharmacodynamics in critically ill infants. Clinical Pharmacology & Therapeutics 60:424-34.
Walker DL, Ressler KJ, Lu KT, Davis M (2002) Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. The Journal of Neuroscience 22:2343-2351.
Welberg LA, Seckl JR, Holmes MC (2001) Prenatal glucocorticoid programming of brain corticosteroid receptors and corticotrophin-releasing hormone: possible implications for behaviour. The Journal of Neuroscience 104:71-79.
Wapner RJ, Sorokin Y, Mele L, Johoson FRN, Dudley DJ, Spon CY, Peaceman AM, Leveno KJ, Malone F, Caritis SN, Mercer B, Harper M, Rouse DJ, Thorp JM, Ramin S, Carpenter MW, Gabbe SG (2007) Long-Term Outcomes after Repeat Doses of Antenatal Corticosteroids. The New England Journal of Medicine 357:1190-8.
Wikstrom MA, Matthews P, Roberts D, Collingridge GL, Bortolotto ZA (2003) Parallel kinase cascades are involved in the induction of LTP at hippocampal CA1 synapses. Neuropharmacology 45:828-836.
Wong D, Abdel-Latif ME, Kent AL (2014) Antenatal steroid exposure and outcomes of very premature infants: a regional cohort study. Archives of Disease in Childhood-Fetal and Neonatal Edition 99:F12-F20
Wang DD, Kriegstein AR (2011) Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits. Cerebral Cortex 21:574-87.
Young EA, Abelson JL, Curtis GC, Nesse RM (1997) Childhood adversity and vulnerability to mood and anxiety disorders. Depression and Anxiety 5:66-72.
Yang YL, Lu KT (2005) Facilitation of conditioned fear extinction by D-cycloserine is mediated by mitogen activated protein kinase and PI-3 kinase cascades and requires de novo protein synthesis in basolateral nucleus of amygdala. The Journal of Neuroscience 134: 247-260.